Pharmaceuticals (Mar 2022)

Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes

  • Jerome P. L. Ng,
  • Mohit K. Tiwari,
  • Ali Adnan Nasim,
  • Rui Long Zhang,
  • Yuanqing Qu,
  • Richa Sharma,
  • Betty Yuen Kwan Law,
  • Dharmendra K. Yadav,
  • Sandeep Chaudhary,
  • Paolo Coghi,
  • Vincent Kam Wai Wong

DOI
https://doi.org/10.3390/ph15030360
Journal volume & issue
Vol. 15, no. 3
p. 360

Abstract

Read online

1,2,4-trioxane is a pharmacophore, which possesses a wide spectrum of biological activities, including anticancer effects. In this study, the cytotoxic effect and anticancer mechanism of action of a set of 10 selected peroxides were investigated on five phenotypically different cancer cell lines (A549, A2780, HCT8, MCF7, and SGC7901) and their corresponding drug-resistant cancer cell lines. Among all peroxides, only 7 and 8 showed a better P-glycoprotein (P-gp) inhibitory effect at a concentration of 100 nM. These in vitro results were further validated by in silico docking and molecular dynamic (MD) studies, where compounds 7 and 8 exhibited docking scores of −7.089 and −8.196 kcal/mol, respectively, and remained generally stable in 100 ns during MD simulation. Further experiments revealed that peroxides 7 and 8 showed no significant effect on ROS accumulations and caspase-3 activity in A549 cells. Peroxides 7 and 8 were also found to decrease cell membrane potential. In addition, peroxides 7 and 8 were demonstrated to oxidize a flavin cofactor, possibly elucidating its mechanism of action. In conclusion, apoptosis induced by 1,2,4-trioxane was shown to undergo via a ROS- and caspase-3-independent pathway with hyperpolarization of cell membrane potential.

Keywords